Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Braun

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|February 2, 2026
Next-generation liquid biopsies: detecting circulating epigenetic changes to identify translocation renal cell carcinomaKatsuhiro Ito, David A Braun
The Urologic Clinics of North America|March 22, 2023
The Changing Landscape of Immunotherapy for Advanced Renal CancerSoki Kashima, David A Braun
Psychological Research|September 28, 2017
Assessing the role of reward in task selection using a reward-based voluntary task switching paradigmDavid A Braun, Catherine M Arrington
Hematology/Oncology Clinics of North America|May 28, 2023
Immunobiology and Metabolic Pathways of Renal Cell CarcinomaDavid A Braun, Abhishek A Chakraborty
The New England Journal of Medicine|March 9, 2022
Tumor-Infiltrating T Cells - A PortraitDavid A Braun, Catherine J Wu
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Antigen Discovery and Therapeutic Targeting in Hematologic MalignanciesDavid A Braun, Catherine J Wu
Kidney Cancer (Clifton, Va.)|November 28, 2023
Antigenic targets in clear cell renal cell carcinomaNicholas R Schindler, David A Braun
Targeted Oncology|April 10, 2025
Immunotherapy for Renal Cell Carcinoma-What More is to Come?Zachary A Yochum, David A Braun
Lancet (London, England)|September 16, 2024
Rechallenging with anti-PD-1 therapy in advanced renal cell carcinomaZachary A Yochum, David A Braun
The Journal of Biological Chemistry|November 21, 2012
Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activationDavid A Braun, Miguel Fribourg, Stuart C Sealfon
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|February 2, 2026
Next-generation liquid biopsies: detecting circulating epigenetic changes to identify translocation renal cell carcinomaKatsuhiro Ito, David A Braun
The Urologic Clinics of North America|March 22, 2023
The Changing Landscape of Immunotherapy for Advanced Renal CancerSoki Kashima, David A Braun
Psychological Research|September 28, 2017
Assessing the role of reward in task selection using a reward-based voluntary task switching paradigmDavid A Braun, Catherine M Arrington
Hematology/Oncology Clinics of North America|May 28, 2023
Immunobiology and Metabolic Pathways of Renal Cell CarcinomaDavid A Braun, Abhishek A Chakraborty
The New England Journal of Medicine|March 9, 2022
Tumor-Infiltrating T Cells - A PortraitDavid A Braun, Catherine J Wu
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Antigen Discovery and Therapeutic Targeting in Hematologic MalignanciesDavid A Braun, Catherine J Wu
Kidney Cancer (Clifton, Va.)|November 28, 2023
Antigenic targets in clear cell renal cell carcinomaNicholas R Schindler, David A Braun
Targeted Oncology|April 10, 2025
Immunotherapy for Renal Cell Carcinoma-What More is to Come?Zachary A Yochum, David A Braun
Lancet (London, England)|September 16, 2024
Rechallenging with anti-PD-1 therapy in advanced renal cell carcinomaZachary A Yochum, David A Braun
The Journal of Biological Chemistry|November 21, 2012
Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activationDavid A Braun, Miguel Fribourg, Stuart C Sealfon
Pageof 10